COVID-19 Vaccination for children

3 March 2022

This article has been migrated from an earlier version of the site and may display formatting inconsistencies.

NOTICE PAPER NO. 1021
NOTICE OF QUESTION FOR ORAL ANSWER
FOR THE SITTING OF PARLIAMENT ON 3 MARCH 2022

Name and Constituency of Member of Parliament
Mr Yip Hon Weng
MP for Yio Chu Kang SMC

Question No. 2598
To ask the Minister for Health (a) whether the Ministry is exploring the authorisation of the Pfizer-BioNTech COVID-19 vaccine for children aged under five years; and (b) with some countries adopting different stands towards vaccination of young children against COVID-19, how does the Ministry decide which is the most suitable strategy for our country.

Answer
The Pfizer-BioNTech COVID-19 vaccine is currently approved for use in individuals aged above five years. The use of vaccine for younger children is still being studied in clinical trials.

MOH, in consultation with the Expert Committee on COVID-19 Vaccination (EC19V), continues to examine different vaccine strategies, based on the risk-benefit assessment to the relevant subpopulation, in the context of the evolving COVID-19 situation.